COMPANY OVERVIEW

Bright Peak Therapeutics develops a novel portfolio of next-generation engineered cytokines for immuno-oncology indications. The company has been incubated within Versant Venture's Ridgeline Discovery Engine in Basel, Switzerland.

---

LOCATION

Basel, , Switzerland

San Diego, CA, USA

---

THERAPEUTIC AREAS

Autoimmune Disease

Oncology

---

WEBSITE

https://www.brightpeaktx.com/

---

CAREER WEBSITE

https://brightpeaktx.com/careers/

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Oct 20, 2022

Bright Peak Therapeutics to Present Innovative Best-in-Class and Multifunctional Regulatory T Cell (Treg) Enhancers at the 10th International Conference on Autoimmunity: Mechanisms and Novel Treatments

Oct 18, 2022

Bright Peak Therapeutics Announces Formation of World Class Immuno-Oncology Scientific Advisory Board

Aug 22, 2022

Bright Peak Therapeutics Announces the Appointment of Cancer Immunotherapy Leader Jon Wigginton, M.D., as President of Research and Development

Apr 4, 2022

Bright Peak Therapeutics Announces Multiple Presentations at the American Association for Cancer Research (AACR) Annual Meeting

Feb 28, 2022

Bright Peak Therapeutics Appoints Leena Gandhi, M.D., Ph.D., to its Board of Directors

For More Press Releases

---